1.47 USD
0 (0%)
1.4993 USD
+0.03 (+1.99%)
We assign a fundamental rating of 2 out of 10 to OSTX. OSTX was compared to 525 industry peers in the Biotechnology industry. OSTX scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. OSTX has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
- In the past year OSTX has reported negative net income.
- In the past year OSTX has reported a negative cash flow from operations.
1.2 Ratios
- With a Return On Assets value of -226.24%, OSTX is not doing good in the industry: 89.71% of the companies in the same industry are doing better.
- Looking at the Return On Equity, with a value of -430.26%, OSTX is doing worse than 74.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -226.24% | ||
| ROE | -430.26% | ||
| ROIC | N/A |
ROA(3y)-813.87%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin and Operating Margin and Gross Margin are not available for OSTX so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- The number of shares outstanding for OSTX has been increased compared to 1 year ago.
- OSTX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- Based on the Altman-Z score of -8.59, we must say that OSTX is in the distress zone and has some risk of bankruptcy.
- Looking at the Altman-Z score, with a value of -8.59, OSTX is doing worse than 69.33% of the companies in the same industry.
- There is no outstanding debt for OSTX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -8.59 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- OSTX has a Current Ratio of 0.56. This is a bad value and indicates that OSTX is not financially healthy enough and could expect problems in meeting its short term obligations.
- OSTX has a Current ratio of 0.56. This is amonst the worse of the industry: OSTX underperforms 89.33% of its industry peers.
- A Quick Ratio of 0.56 indicates that OSTX may have some problems paying its short term obligations.
- OSTX's Quick ratio of 0.56 is on the low side compared to the rest of the industry. OSTX is outperformed by 89.14% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.56 | ||
| Quick Ratio | 0.56 |
3. Growth
3.1 Past
- The earnings per share for OSTX have decreased strongly by -174.65% in the last year.
EPS 1Y (TTM)-174.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-16.67%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
- Based on estimates for the next years, OSTX will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.92% on average per year.
- The Revenue is expected to grow by 247.07% on average over the next years. This is a very strong growth
EPS Next Y34.56%
EPS Next 2Y26.29%
EPS Next 3Y22.71%
EPS Next 5Y13.92%
Revenue Next Year-100%
Revenue Next 2Y771.98%
Revenue Next 3Y445.88%
Revenue Next 5Y247.07%
3.3 Evolution
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for OSTX. In the last year negative earnings were reported.
- Also next year OSTX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- OSTX's earnings are expected to grow with 22.71% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.29%
EPS Next 3Y22.71%
5. Dividend
5.1 Amount
- No dividends for OSTX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
OS THERAPIES INC / OSTX FAQ
Can you provide the ChartMill fundamental rating for OS THERAPIES INC?
ChartMill assigns a fundamental rating of 2 / 10 to OSTX.
Can you provide the valuation status for OS THERAPIES INC?
ChartMill assigns a valuation rating of 1 / 10 to OS THERAPIES INC (OSTX). This can be considered as Overvalued.
How profitable is OS THERAPIES INC (OSTX) stock?
OS THERAPIES INC (OSTX) has a profitability rating of 0 / 10.
How financially healthy is OS THERAPIES INC?
The financial health rating of OS THERAPIES INC (OSTX) is 4 / 10.
What is the expected EPS growth for OS THERAPIES INC (OSTX) stock?
The Earnings per Share (EPS) of OS THERAPIES INC (OSTX) is expected to grow by 34.56% in the next year.